Structure | Chemical Name | CAS | MF |
|
(4E)-4-benzylidene-3-(chloromethyl)isoxazol-5(4H)-one
|
|
C11H8ClNO2
|
|
3-[(E)-Benzylidene]tetrahydrofuran-2-one
|
|
|
|
(3E)-3-(Benzylidene)-5-[4-(methoxycarbonyl)phenyl]furan-2(3H)-one
|
|
|
|
2-[(E)-Benzylidene]-5-(4-methylbenzyl)cyclopentane-1-one
|
|
|
|
(E)-2-Benzoylamino-3-(3-methoxyphenyl)propenoic acid methyl ester
|
|
|
|
(1E)-2-Benzyl-1-[(2E)-2-hydroxyimino-2-(4-trifluoromethylphenyl)ethylidene]-1H-isoindol-3(2H)-one
|
|
|
|
(E)-2-Benzoylamino-3-(3-nitrophenyl)propenoic acid methyl ester
|
|
|
|
(E)-3-[4-Benzyloxyphenyl]-N-methyl-2-propenehydroxamic acid
|
|
|
|
1-((E)-4-BENZENESULFONYL-3-METHYL-BUT-2-ENVYL)-2,4,5-TETRAMETHOXY-6-METHYL BENZENE
|
73875-21-5
|
C21H26O5S
|
|
(E)-4-(5-BENZYL-FURAN-2-YL)-BUT-3-EN-2-ONE
|
101093-49-6
|
C15H14O2
|
|
EA optical plastics
|
|
|
|
Eberconazole
|
128326-82-9
|
C18H14Cl2N2
|
|
(E)-A-PHENYLCINNAMICACID
|
|
C15H12O2
|
|
(E)-α-bergamotene,(-)-trans-α-bergamotene
|
13474-59-4
|
|
|
ebericol
|
6890-88-6
|
C31H52O
|
|
Eapidil
|
|
|
|
EAPII (ETS1-Associated Protein 2)
|
|
|
|
EAP-II protocol
|
|
|
|
E27 beta(2)-adrenergic receptor
|
|
|
|
(E)-beta-fluoromethylene-m-tyramine
|
85278-68-8
|
|
|
(E)-BETA,2,3,4,5,6-HEXACHLOROSTYRENE
|
|
C8H2Cl6
|
|
(E)-BETA-FARNESENE
|
18794-84-8
|
C15H24
|
|
(E)-beta-Farnesene
|
28973-97-9
|
C15H24
|
|
(20E)-3beta-hydroxypregna-5,16-dien-20-one 20-oxime 3-acetate
|
23549-24-8
|
C23H32NO4-
|
|
(E)-beta-methoxy-alpha-methylstyrene
|
58966-09-9
|
C10H12O
|
|
Triapenthenol
|
76608-88-3
|
C15H25N3O
|
|
EBFP:Enhanced Blue Fluorescent Protein
|
|
|
|
ebg gene product
|
|
|
|
Ebf3 protein
|
|
|
|
EAP45 protein
|
|
|
|
Ebf2 protein
|
|
|
|
EBF3 protein, human
|
|
|
|
EAP protocol
|
|
|
|
EAP20 protein
|
|
|
|
EAR
|
|
|
|
E1A protein 243R, adenovirus 5
|
|
|
|
E5A protein, human papillomavirus type 11
|
|
|
|
EBH-2 BLOCK HOLDER (BOX OF 50)
|
|
|
|
(3E,9aR)-3-Ethylidene-3,3aα,4aβ,7,7aβ,9bβ-hexahydro-6β-hydroxy-2-oxo-2H,6H-1,4,5-trioxadicyclopent[a,hi]indene-7α-carboxylic acid methyl ester
|
|
|
|
earex
|
|
|
|
(E)-5-[(3aR)-2-Formyl-3a,4,5,6,7,7aα-hexahydro-3,3aβ,6β,7-tetramethyl-1H-inden-7α-yl]-3-methyl-2-pentenoic acid
|
97868-05-8
|
|
|
EAQQHMLQLTVWGIK
|
|
C80H128N22O22S
|
|
EAQQHMLQLTVWGIKQLQAR
|
|
C105H172N32O29S
|
|
ebg repressor protein
|
|
|
|
EC 27
|
23356-91-4
|
|
|
EC 33
|
|
|
|
EC 3.4.21.5
|
9014-41-9
|
|
|
EC 1.6.2.4
|
9039-06-9
|
|
|
EC2
|
9060-77-9
|
|
|
EC 4.1.1.19
|
9024-77-5
|
|
|
EC 2.3.2.2
|
9046-27-9
|
|
|
EC 3.1.1.1
|
9016-18-6
|
NULL
|
|
EC 5.3.4.1
|
37318-49-3
|
|
|
EC 1.1.1.48
|
9028-54-0
|
|
|
EC 1.14.14.3
|
9014-00-0
|
|
|
EC 2.2.1.1
|
9014-48-6
|
|
|
EC 2.8.1.1
|
9026-04-4
|
|
|
EC 2.7.7.4
|
9012-39-9
|
|
|
EC 3.4.21.14
|
9014-01-1
|
NULL
|
|
EC 4.3.1.5
|
9024-28-6
|
|
|
EC 4.1.1.31
|
9067-77-0
|
NULL
|
|
EC 2.6.1.1
|
9000-97-9
|
C13H17NO2
|
|
EC 3.1.4.2
|
9025-85-8
|
|
|
EC 1.1.3.4
|
9001-37-0
|
NULL
|
|
EC 3.5.3.15
|
75536-80-0
|
|
|
EC-4
|
|
|
|
EC 2.4.2.4
|
9030-23-3
|
|
|
EC 1.1.1.42
|
9028-48-2
|
NULL
|
|
Propargyl alcohol propoxylate
|
9001-77-8
|
C6H10O2
|
|
EC 3.4.22.15
|
|
|
|
EC 3.1.3.25
|
37184-63-7
|
|
|
EC 3.2.1.1
|
9000-85-5
|
NULL
|
|
EC 3.5.5.1
|
|
|
|
EC 1.1.1.18
|
9028-25-5
|
|
|
EC 3.2.1.37
|
9025-53-0
|
|
|
EC 1.1.1.8
|
9075-65-4
|
NULL
|
|
EC 1.1.1.2
|
|
|
|
EC 1.18.1.2
|
9029-33-8
|
|
|
EC 3.1.1.8
|
9001-08-5
|
|
|
EC 6.3.1.2
|
9023-70-5
|
|
|
EC 4.1.3.3
|
9027-60-5
|
|
|
EC 3.2.1.8
|
37278-89-0
|
|
|
EC 1.1.1.47
|
9028-53-9
|
NULL
|
|
EC 4.1.1.1
|
9024-43-5
|
|
|
EC 1.5.1.11
|
37256-27-2
|
|
|
EC 2.6.1.2
|
9000-86-6
|
|
|
EC: 3.4.21.22
|
|
|
|
EC 1.14.13.1
|
9059-28-3
|
|
|
EC 3.1.1.11
|
9025-98-3
|
|
|
EC 1.1.1.205
|
|
|
|
EC 2.7.11
|
|
|
|
EC 1.1.3.21
|
|
|
|
EC 2.4.1.65
|
|
|
|
EC 3.5.1.4
|
9012-56-0
|
|
|
EC 2.3.2.13
|
80146-85-6
|
C27H44O3H2O
|
|
EC 2.7.1.40
|
9001-59-6
|
NULL
|
|
EC 3.2.1.20
|
9001-42-7
|
NULL
|
|
EC 1.13.11.33
|
|
|
|
EC 3.4.21.19
|
66676-43-5
|
NULL
|
|
EC 3.4.23.34
|
|
|